Tech Center 1600 • Art Units: 1641 1663 1671
This examiner grants 38% of resolved cases
Kristina Elisabeth Ly is a patent examiner in Tech Center 1600, working within Art Unit 1641. The current data for this examiner is based on 8 resolved cases. This small sample size results in an allowance rate of 37.5 percent. Practitioners should view this rate as a preliminary indicator of the examiner's tendencies, noting that the 37.5 percent figure may fluctuate as more cases are resolved in Art Unit 1641.
A significant data point is the interview lift of 100.0 percent. This suggests that every allowance granted by this examiner so far was associated with an interview. While the 37.5 percent allowance rate is relatively low, the 100.0 percent lift indicates that direct communication is an exceptionally effective strategy. Applicants should prioritize interviews to navigate the complexities of this examiner's review process.
The median days to allowance is 1086, which establishes the expected timeline for successful prosecution. With 8 resolved cases, the examiner's profile is still developing, but the 1086-day duration provides a useful benchmark. Given the 100.0 percent interview lift, practitioners have a clear tactical path to improve their chances of success despite the current 37.5 percent allowance rate. This proactive approach may be essential for overcoming rejections in Tech Center 1600.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18278775 | NOVEL BACTERIOPHAGE HAVING ABILITY TO SPECIFICALLY KILL CLOSTRIDIUM PERFRINGENS AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME | Final Rejection | CJ CheilJedang Corporation |
| 18290259 | ENGINEERING STEM CELLS FOR ALLOGENIC CAR T CELL THERAPIES | Non-Final OA | The Regents of the University of California |
| 18558973 | HUMAN ANTI-CORONAVIRUS PEPTIDE VACCINES AND METHODS OF THEIR USE | Non-Final OA | Ohio State Innovation Foundation |
| 18779108 | METHOD AND KIT FOR DETECTING INFLUENZA A AND B VIRUSES | Non-Final OA | DELTA ELECTRONICS, INC. |
| 18286657 | METHOD FOR PRODUCING VIRUS PARTICLES | Non-Final OA | The University of Tokyo |
| 18363520 | METHOD FOR SELECTING ANTIGENIC VIRAL SEQUENCES FOR VACCINES AND THERAPEUTICS | Non-Final OA | THE CURATORS OF THE UNIVERSITY OF MISSOURI |
| 18257215 | HILIC UPLC-MS Method For Separating and Analyzing Intact Adeno-Associated Virus Capsid Proteins | Non-Final OA | Pfizer Inc. |
| 18436287 | COTTON LEAFROLL DWARF VIRUS-BINDING ANTIBODIES AND USES THEREOF | Non-Final OA | Cornell University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy